Matthieu Thumerel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Matthieu Thumerel has a total of 202 co-authors. Here are the top co-authors by number of shared publications:
Jacques Jougon
Department of Thoracic Surgery, Haut-Leveque Hospital, Bordeaux University , Pessac 33600
10 shared publications- Isabelle Dupin
University of Bordeaux, INSERM, CRCTB, U 1045
9 shared publications - Patrick Berger
Centre de Recherche Cardio-Thoracique de Bordeaux, Université de Bordeaux, INSERM, Pessac, France
8 shared publications Elise Maurat
Univ-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, CIC1401, Pessac, France
6 shared publicationsYaniss Belaroussi
CHU Bordeaux, Department of Thoracic Surgery, Magellan Medico-Surgical Centre, Pessac, France
6 shared publicationsHugues Begueret
Department of Anathomopathology, Haut-Leveque Hospital, Bordeaux University , Pessac, France
5 shared publications
Latest Publications
- 1 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Approche translationnelle du remodelage bronchique dans la broncho-pneumopathie chronique obstructive et l’asthme
Le remodelage bronchique regroupe des entités physiopaphologiques commel’hypertrophie musculaire lisse dans l’asthme ou l’augmentation d’épaisseur bronchique surl’infiltration de cellules inflammatoires et l’accumulation de fibrose dans la BPCO. Cesremodelages sont corrélés à l’obstruction fonctionnelle et donc à la sévèrité de ces maladies.L’analyse de biopsies bronchique ou pulmonaire permet d’étudier ce phénoméne qui, aprèsune meilleure compréhension, est une cible thérapeutique intérressante. Le premier articleest une revue d’indications de bronchoscopie chez les patients de réanimation. La deuxièmeétude a montré une augmentation des fibrocytes sanguins au cours d’exacerbation sévèrede patient BPCO et une corrélation entre leur taux et le risque de décès du patient. La voiede signalisation du CXCR4 semble impliquée dans ce recrutement. La troisième étudecherche à explorer la localisation et les caractéristiques intra-pulmonaires des fibrocyteschez le patient BPCO à l’état stable. La quatrième étude a montré, in vivo, que le gallopamil,un inhibiteur calcique, pouvait diminuer la taille de muscle lisse bronchique de patientasthmatique sévère en ciblant la biogenèse mitochondriale. Ceci pourrait en faire une armethérapeutique interressante et totalement novatrice. La dernière étude a permis d’isoler unphénotype de patient asthmatique non sévère à « muscle lisse bronchique augmenté » quiprésente un risque accru d’exacerbation et de contrôle non optimal de leur asthme. Lesmitochondries semblent jouer un rôle clé comme dans l’asthme sévère.
- 1 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Approche translationnelle du remodelage bronchique dans la broncho-pneumopathie chronique obstructive et l’asthme
Le remodelage bronchique regroupe des entités physiopaphologiques commel’hypertrophie musculaire lisse dans l’asthme ou l’augmentation d’épaisseur bronchique surl’infiltration de cellules inflammatoires et l’accumulation de fibrose dans la BPCO. Cesremodelages sont corrélés à l’obstruction fonctionnelle et donc à la sévèrité de ces maladies.L’analyse de biopsies bronchique ou pulmonaire permet d’étudier ce phénoméne qui, aprèsune meilleure compréhension, est une cible thérapeutique intérressante. Le premier articleest une revue d’indications de bronchoscopie chez les patients de réanimation. La deuxièmeétude a montré une augmentation des fibrocytes sanguins au cours d’exacerbation sévèrede patient BPCO et une corrélation entre leur taux et le risque de décès du patient. La voiede signalisation du CXCR4 semble impliquée dans ce recrutement. La troisième étudecherche à explorer la localisation et les caractéristiques intra-pulmonaires des fibrocyteschez le patient BPCO à l’état stable. La quatrième étude a montré, in vivo, que le gallopamil,un inhibiteur calcique, pouvait diminuer la taille de muscle lisse bronchique de patientasthmatique sévère en ciblant la biogenèse mitochondriale. Ceci pourrait en faire une armethérapeutique interressante et totalement novatrice. La dernière étude a permis d’isoler unphénotype de patient asthmatique non sévère à « muscle lisse bronchique augmenté » quiprésente un risque accru d’exacerbation et de contrôle non optimal de leur asthme. Lesmitochondries semblent jouer un rôle clé comme dans l’asthme sévère.
- Top Cited PapersOpen Access
Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis
Objectives: Pulmonary metastasectomy is not a standardised procedure, with no consensus regarding the optimal extent of lung resection. This international multicentre study aimed at comparing short and long-term outcomes of anatomical versus non-anatomical pulmonary metastasectomy. Methods: Retrospective database including 1647 patients aged ≥18 years, who underwent curative intent pulmonary metastasectomy between January 2010 and December 2018 at 15 European centres. Patients who underwent pneumonectomy, previous metastasectomies, and/or suffered from extrapulmonary recurrence at the time of lung surgery were excluded. Primary endpoint was overall survival. Secondary endpoints were recurrence-free survival and 30-day morbidity. Differences between the two groups were analysed using 3:1 matching. Results: In the matched cohort, 324 patients underwent anatomical resection, and 830 patients underwent non-anatomical resection. Five-year overall survival was 62.0%. Averaged over the entire follow-up, there was no significant difference in overall survival between the two groups (HR = 1.122, 95% CI = 0.909–1.385, p = 0.283). In the early period following pulmonary metastasectomy, anatomical resections were associated with worse overall survival (HR = 1.549, 95% CI = 1.135–2.114, p = 0.006). The difference in any-site recurrence-free survival between the two groups was not significant (HR = 0.832, 95% CI = 0.690–1.002, p = 0.053). Locoregional recurrence-free survival was significantly longer after anatomical resection (HR = 0.651, 95% CI = 0.520–0.817, p < 0.001). Thirty-day morbidity was significantly higher after anatomical resection (22.2% versus 13.7% for non-anatomical resections, p = 0.001). Conclusions: In a highly selected cohort, non-anatomical resection showed comparable survival and lower morbidity compared to anatomical resections, supporting the surgical strategy of favouring limited resections whenever technically and oncologically feasible. Anatomical resections remain a valid option in selected cases with acceptable outcomes.
Top Cited PapersOpen AccessAnatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis
Objectives: Pulmonary metastasectomy is not a standardised procedure, with no consensus regarding the optimal extent of lung resection. This international multicentre study aimed at comparing short and long-term outcomes of anatomical versus non-anatomical pulmonary metastasectomy. Methods: Retrospective database including 1647 patients aged ≥18 years, who underwent curative intent pulmonary metastasectomy between January 2010 and December 2018 at 15 European centres. Patients who underwent pneumonectomy, previous metastasectomies, and/or suffered from extrapulmonary recurrence at the time of lung surgery were excluded. Primary endpoint was overall survival. Secondary endpoints were recurrence-free survival and 30-day morbidity. Differences between the two groups were analysed using 3:1 matching. Results: In the matched cohort, 324 patients underwent anatomical resection, and 830 patients underwent non-anatomical resection. Five-year overall survival was 62.0%. Averaged over the entire follow-up, there was no significant difference in overall survival between the two groups (HR = 1.122, 95% CI = 0.909–1.385, p = 0.283). In the early period following pulmonary metastasectomy, anatomical resections were associated with worse overall survival (HR = 1.549, 95% CI = 1.135–2.114, p = 0.006). The difference in any-site recurrence-free survival between the two groups was not significant (HR = 0.832, 95% CI = 0.690–1.002, p = 0.053). Locoregional recurrence-free survival was significantly longer after anatomical resection (HR = 0.651, 95% CI = 0.520–0.817, p < 0.001). Thirty-day morbidity was significantly higher after anatomical resection (22.2% versus 13.7% for non-anatomical resections, p = 0.001). Conclusions: In a highly selected cohort, non-anatomical resection showed comparable survival and lower morbidity compared to anatomical resections, supporting the surgical strategy of favouring limited resections whenever technically and oncologically feasible. Anatomical resections remain a valid option in selected cases with acceptable outcomes.
- 30 July 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (8)
Postoperative Acute Kidney Injury Requiring Dialysis After Lung Transplantation: Factors Associated and Long-term Outcomes
Objectives: Acute kidney injury (AKI) requiring dialysis after lung transplantation is a significant source of morbidity. This study investigates the incidence, mortality, and variables associated with the need for dialysis. Methods: This retrospective analysis included patients aged ≥15 years who underwent lung transplantation between 2014 and 2019 at 3 French institutions. Patients were grouped based on the need for dialysis in the postoperative period. Outcomes analysed included the incidence of AKI requiring dialysis and short- and long-term mortality. We also examined the association between recipient, donor, and intraoperative variables and the need for dialysis. Results: The study population consisted of 478 patients, with a mean age of 49.7 (SD 14.3) years. Dialysis was required for 88 patients (18.4%). In multivariable logistic regression, recipient characteristics (diagnosis), donor characteristics (cardiac arrest), and intraoperative variables (total ischaemic time, norepinephrine dose at the end of the procedure, red blood cell and plasma transfusions) were independently associated with postoperative dialysis (P < 0.05). The median overall survival for patients requiring dialysis was 6.2 months (not reached for those without dialysis). Patients requiring dialysis had a higher risk of all-cause mortality (P < 0.01), with higher 30-day (29.5% vs 7.2%) and 1-year (63.6% vs 13.4%) mortality rates. Conclusions: AKI requiring dialysis after lung transplantation is associated with significantly higher 30-day and long-term mortality. Identifying high-risk patients for postoperative renal failure requiring dialysis may improve long-term outcomes after lung transplantation.
- 30 July 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (8)
Postoperative Acute Kidney Injury Requiring Dialysis After Lung Transplantation: Factors Associated and Long-term Outcomes
Objectives: Acute kidney injury (AKI) requiring dialysis after lung transplantation is a significant source of morbidity. This study investigates the incidence, mortality, and variables associated with the need for dialysis. Methods: This retrospective analysis included patients aged ≥15 years who underwent lung transplantation between 2014 and 2019 at 3 French institutions. Patients were grouped based on the need for dialysis in the postoperative period. Outcomes analysed included the incidence of AKI requiring dialysis and short- and long-term mortality. We also examined the association between recipient, donor, and intraoperative variables and the need for dialysis. Results: The study population consisted of 478 patients, with a mean age of 49.7 (SD 14.3) years. Dialysis was required for 88 patients (18.4%). In multivariable logistic regression, recipient characteristics (diagnosis), donor characteristics (cardiac arrest), and intraoperative variables (total ischaemic time, norepinephrine dose at the end of the procedure, red blood cell and plasma transfusions) were independently associated with postoperative dialysis (P < 0.05). The median overall survival for patients requiring dialysis was 6.2 months (not reached for those without dialysis). Patients requiring dialysis had a higher risk of all-cause mortality (P < 0.01), with higher 30-day (29.5% vs 7.2%) and 1-year (63.6% vs 13.4%) mortality rates. Conclusions: AKI requiring dialysis after lung transplantation is associated with significantly higher 30-day and long-term mortality. Identifying high-risk patients for postoperative renal failure requiring dialysis may improve long-term outcomes after lung transplantation.
- Open Access
- 4 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (6) , 2400562
A novelin vitrotubular model to recapitulate features of distal airways: the bronchioid
Background: Airflow limitation is the hallmark of obstructive pulmonary diseases, with the distal airways representing a major site of obstruction. Although numerousin vitromodels of bronchi already exist, there is currently no culture system for obstructive diseases that reproduces the architecture and function of small airways. Here, we aimed to engineer a model of distal airways to overcome the limitations of current culture systems.Methods: We developed a so-called bronchioid model by encapsulating human bronchial adult stem cells derived from clinical samples in a tubular scaffold made of alginate gel.Results: This template drives the spontaneous self-organisation of epithelial cells into a tubular structure. Fine control of the level of contraction is required to establish a model of the bronchiole, which has a physiologically relevant shape and size. Three-dimensional imaging, gene expression and single-cell RNA-sequencing analysis of bronchioids made of bronchial epithelial cells revealed tubular organisation, epithelial junction formation and differentiation into ciliated and goblet cells. Ciliary beating was observed, at a decreased frequency in bronchioids made of cells from COPD patients. The bronchioid could be infected by rhinovirus. An air–liquid interface was introduced that modulated gene expression.Conclusion: Here, we provide a proof of concept of a perfusable bronchioid with proper mucociliary and contractile functions. The key advantages of our approach, such as the air‒liquid interface, lumen accessibility, recapitulation of pathological features and possible assessment of clinically relevant end-points, will make our pulmonary organoid-like model a powerful tool for preclinical studies.
- 4 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (6) , 2400562
Open AccessA novelin vitrotubular model to recapitulate features of distal airways: the bronchioid
Background: Airflow limitation is the hallmark of obstructive pulmonary diseases, with the distal airways representing a major site of obstruction. Although numerousin vitromodels of bronchi already exist, there is currently no culture system for obstructive diseases that reproduces the architecture and function of small airways. Here, we aimed to engineer a model of distal airways to overcome the limitations of current culture systems.Methods: We developed a so-called bronchioid model by encapsulating human bronchial adult stem cells derived from clinical samples in a tubular scaffold made of alginate gel.Results: This template drives the spontaneous self-organisation of epithelial cells into a tubular structure. Fine control of the level of contraction is required to establish a model of the bronchiole, which has a physiologically relevant shape and size. Three-dimensional imaging, gene expression and single-cell RNA-sequencing analysis of bronchioids made of bronchial epithelial cells revealed tubular organisation, epithelial junction formation and differentiation into ciliated and goblet cells. Ciliary beating was observed, at a decreased frequency in bronchioids made of cells from COPD patients. The bronchioid could be infected by rhinovirus. An air–liquid interface was introduced that modulated gene expression.Conclusion: Here, we provide a proof of concept of a perfusable bronchioid with proper mucociliary and contractile functions. The key advantages of our approach, such as the air‒liquid interface, lumen accessibility, recapitulation of pathological features and possible assessment of clinically relevant end-points, will make our pulmonary organoid-like model a powerful tool for preclinical studies.
- 1 May 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 65 (5)
Giant thoracic calcinosis
- 1 May 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 65 (5)
Giant thoracic calcinosis
- 19 March 2024
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 85 (4) , 323-324
Ectopic thoracic parathyroid adenoma: The thoracic surgeon needs multi-approach skills!
- 19 March 2024
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 85 (4) , 323-324
Ectopic thoracic parathyroid adenoma: The thoracic surgeon needs multi-approach skills!
- 17 October 2023
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 84 (6) , 764-766
Parathyroid adenoma in the sternocleidomastoid muscle 30 years after thyroidectomy
- 17 October 2023
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 84 (6) , 764-766
Parathyroid adenoma in the sternocleidomastoid muscle 30 years after thyroidectomy
- 10 August 2022
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 114 (6) , 2379-2382
Immersive Three-dimensional Computed Tomography to Plan Chest Wall Resection for Lung Cancer
- 10 August 2022
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 114 (6) , 2379-2382
Immersive Three-dimensional Computed Tomography to Plan Chest Wall Resection for Lung Cancer